If traveling internationally, verify destination country import rules
The raw data generated and/or analyzed during the current study are available from the corresponding author upon reasonable request
Its architecture is similar to Swell's in principle: headless, API-centric, and fully customizable
Mean weight loss was 10.29% with mazdutide versus 6.00% with semaglutide
LLC TNKase (tenecteplase) Approval Date : March 2025 New Indication : FDA Approves Genentechs TNKase in Acute Ischemic Stroke in Adults Why It Matters: TNKase offers a simpler, faster alternative to existing stroke treatments with a single five-second IV bolus
While insulin remains the cornerstone of T1D treatment, many patients struggle to achieve optimal glycaemic targets, leading to an increased risk of long-term complications, including DKD